Most healthy patients are good candidates for VelaShape treatment, but the following types of people are not suitable for treatment with VelaShape: - Patients with type I or II diabetes - Patients with anticoagulative conditions - Patients prone to blood clots - Photosensitive or sunburnt patients (tanned skin is okay) - Pregnant women (patients should wait until after giving birth to have this treatment) - People with pacemakers, heart valves, metal hip joints or dental plates Is VelaShape safe
Food and Drug Administration's Pharmacy Compounding Advisory Committee reviewed AOD-9604 alongside other unapproved peptides and recommended against allowing the compound to be used in 503A pharmacy compounding
What dose should be given
Peripheral neuropathy may take 36 months to improve, and some patients experience incomplete recovery, particularly if treatment was delayed
Symptoms of vitamin B12 deficiency include weakness, anemia, and neurological issues, making regular monitoring through blood tests important for those with ulcerative colitis